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INTRODUCTION 
The management of persistent tracheoesophageal fistulas (TEF) after laryngectomy in 
previously irradiated patients is challenging. A persistent TEF can develop spontaneously or 
result from the enlargement of a tracheoesophageal puncture (TEP) harboring the voice 
prosthesis (VP) (1). Patients treated with radiotherapy are especially at risk of TEP 
enlargement, with an incidence as high as 17% after pre-laryngectomy and 27% after post-
laryngectomy radiotherapy (2). A TEF or enlarged TEP lead to leakage of fluids and food 
into the trachea. In case of an enlarged TEP, spontaneous shrinking or closing may be 
achieved by removing the VP. This requires the insertion of a tracheal cannula with inflated 
cuff and feeding via nasogastric or percutaneous gastric tube to avoid aspiration. Other 
conservative measures include placement of an anterior collar around the VP, and the 
injection of fat or collagen to corset the TEP (1). When conservative treatments fail, closure 
of an enlarged TEP can be achieved by purse string suture or more complex closing 
techniques, using pedicled or free flap reconstructions (3,4).  
When surgery is not successful or impossible because of comorbidities, options are 
limited. Herzog et al. have described TEF closure by means of customized 
pharyngoesophageal stents (5,6). These stents are usually inserted in general anesthesia and 
cannot be removed and cleaned by the patient. They may also hinder physiological peristalsis 
and carry the risk of food impaction.  
We describe the development of a customized removable tracheal prosthesis intended 
to close the TEF, allowing oral nutrition without aspiration and phonation with an 
incorporated VP.  
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MATERIALS AND METHODS 
Case report 
A 52-year old man with a history of cigarette smoking, substance use, alcohol 
dependence, and important co-morbidities such as chronic obstructive pulmonary disease, 
hepatitis C, HIV-infection and general cachexia, was treated with radiotherapy for a right 
vocal fold cancer in 2011. Due to recurrence, he underwent salvage total laryngectomy and 
bilateral neck dissection in 2012. To decrease the risk of TEF formation, a pectoralis major 
myofascial flap was placed on the pharyngeal suture to interpose non-irradiated tissue 
between the neopharynx and the skin (7). The TEP and VP insertion were performed during 
the same operation. Six months later, gradual atrophy of the tissue around the VP occurred 
with consecutive periprosthetic leakage of saliva. The VP was removed and the patient was 
nourished through a percutaneous gastric tube. To avoid pulmonary aspiration, the patient 
had to wear a cuffed tracheal cannula. However, conservative measures did not lead to 
narrowing or closure of the TEF and it eventually reached a size of 2.0 x 1.5 cm (Figure 1). 
Surgical closure of the TEF by radial forearm flap was proposed, but given the co-morbidities 
and considerable perioperative risks, the patient objected to surgery, although his quality of 
life was severely affected. We therefore developed the idea of a customized tracheal 
prosthesis to close the TEF, permitting oral nutrition and speech rehabilitation. 
 
Casting of the tracheostomy and modeling of the prosthesis 
A schematic drawing of the prosthesis is shown in Figure 2. The first step is the 
elaboration of a silicone cast of the tracheostomy, the proximal trachea and the TEF in 
general anesthesia (Figure 3). The patient is ventilated over a cuffed tracheal cannula 
preventing aspiration of liquid silicone. We use a Sengstaken tube (Rüsch, Teleflex 
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Incorporated, Wayne, PA, USA) to seal the esophagus during the procedure, with its long 
proximal cuff lying behind the TEF. A layer of Vaseline is applied on the part of the cuff of 
the Sengstaken tube that is visible through the TEF to prevent sticking of the liquid silicone. 
The tracheostomy and proximal trachea are filled with two-part silicone (StecoForm® Flex, 
steco-system-technik, Hamburg, Germany), which is allowed to harden for 5 minutes before 
it is removed with the still inflated tracheal cannula (Figure 4A and 4B). After removal of the 
Sengstaken tube, the cast is inserted again and its anatomic accuracy verified by flexible 
esophagoscopy. 
Then, a wax model of the prosthesis matching the silicone cast is elaborated, with 
sockets for the VP, the moisturizing filter and bails for the fixation band. A cast out of plaster 
is formed using the wax model. The prosthesis is molded in the plaster cast using FX-502 
Silicone-Elastomer® (Factor II, Lakeside, AZ , USA) around a tubular placeholder which 
creates the lumen of the prosthesis (Figure 4C). Polymerization of the silicone is achieved by 
heating the prosthesis to 100 degrees Celsius in a hot air sterilizer for 90 minutes. Finally, the 
socket for the VP is perforated and a Provox® VegaTM prosthesis (Atos Medical, Sweden) 
inserted. If necessary, minor changes to the shape of the prosthesis can be made after an 
initial fitting. 
 
RESULTS 
Figure 5 shows the finished prosthesis. The prosthesis is very well tolerated by the 
patient who wears it day and night since March 2013. The sealing of the TEF is sufficient to 
enable oral nutrition. The leak tightness can be verified by flexible tracheoscopy through the 
prosthesis lumen while the patient is swallowing a colored liquid and solid food. No 
aspiration pneumonia has occurred since the prosthesis was implemented. 
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The patient removes and reinserts the prosthesis by himself for cleaning with ordinary 
soap water once a day. The phonation with the VP is comparable to that of other 
laryngectomees. Tightness of the prosthesis around the VP is enduring and periprosthetic 
leakage never occurred. The possibility to remove the prosthesis facilitates cleaning of the 
VP. The initial VP remained functional until the whole prosthesis had to be replaced after 
two years due to important fungal colonization. A new prosthesis was molded using the 
initial plaster cast. Three years after the first fitting, leaking occurred due to a slight 
enlargement of the TEF and a second model was elaborated in identical technique. 
 
DISCUSSION 
The presented technique is an innovative approach to close TEF by means of a 
customized silicone tracheal prosthesis.  
Salvage laryngectomy after radiotherapy bears a high risk for the development of TEF 
(2). When conservative measures fail and surgical closure is not feasible, the affected patients 
permanently rely on enteral feeding and the use of a VP is impossible. Their quality of life is 
therefore severely impaired.  
Our removable customized tracheal prosthesis is intended to seal the TEF over a long 
period of time. Oral uptake of nutrition and prosthetic speech is possible, which improves 
patients’ daily life considerably. Besides a fungal colonization of the prosthesis, no other side 
effects like proliferation of granulation tissue, dislocation, leakage and discomfort were 
observed for 3 years. 
Other authors have described sealing of TEF with customized pharyngoesophageal 
stents. Herzog et al. use a different type of prosthesis featuring an additional 
pharyngoesophageal lining in the shape of a tube or a plate, anchoring the prosthesis in the 
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TEF (5,6). An additional esophageal tube may simultaneously serve as a stent to bridge a 
stenosis. Their technique allowed oral feeding and prosthetic speech in some cases.  
There are several advantages to removable prosthesis limited to the trachea. First, 
insertion is easy and does not require general anesthesia. In case of dislocation, the prosthesis 
can easily be put back into position. Second, maintenance of both, the prosthesis and the VP 
is easy, as it can be removed. Furthermore, minor adjustments to the shape of the prosthesis 
can be made after an initial fitting, for example if the patient feels discomfort because of too 
much pressure on the tissue. Third, since the prosthesis presented here is confined to the 
trachea, it does not affect the physiological properties of the esophagus. Stenting of the 
esophagus is much more likely to impair peristalsis and stents are prone to food impaction. 
Self-expansible esophageal stents have also been used to seal TEF, but they have similar 
adverse effects on the esophageal physiology. Additionally, they carry the risks of further 
pressure-induced enlargement of the TEF, perforation, stent migration, hemorrhage and pain 
(8). Our removable prosthesis proves that stenting of the esophagus from inside is not 
necessary to achieve sufficient sealing.  
Possible complications of any prosthesis for closure of a TEF are fungal colonization 
and further enlargement of the TEF caused by friction on the surrounding tissue, as it was the 
case in our patient after three years. Nevertheless, the benefits of the prosthesis and the 
positive effect on the quality of life clearly outweigh these problems. 
In conclusion, this novel customized tracheal prosthesis offers a safe and valuable 
alternative for the treatment of selected cases of TEF. The customized shape of the prosthesis 
allows optimal sealing and efficiently prevents aspiration. For patients, maintenance of the 
prosthesis is easy and they benefit from the possibility to eat and speak using the incorporated 
VP.  
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FIGURE LEGENDS 
Figure 1:  Tracheostomy and tracheoesophageal fistula (TEF). 
 
Figure 2:  Schematic illustration of the removable tracheal prosthesis. 1, neopharynx; 2, 
prosthesis; 3, tracheoesophageal fistula; 4, esophagus; 5, trachea  
 
Figure 3: Schematic illustration of the elaboration of the silicone cast of the tracheostomy 
and the tracheoesophageal fistula. 1, silicone cast; 2, tracheal cannula with 
inflated cuff; 3, liquid silicone; 4, Sengstaken tube; 5, tracheoesophageal fistula 
 
Figure 4:  Casting of the tracheostomy. (A) Filling of the tracheostomy with liquid 
silicone. (B) Hardened silicone cast of the tracheostomy and the 
tracheoesophageal fistula (TEF) with tracheal canula. (C) Molding of the 
prosthesis in casts made out of plaster. The plaster was formed from a wax 
model of the prosthesis. 
 
Figure 5: Finished prosthesis. (A) Prosthesis with voice prosthesis and moisturizing filter. 
(B) Inserted prosthesis with moisturizing filter and bails for the fixation strap. 
 
